Cannabis Stock News- Investing in Cannabis and Hemp Stocks : 2023

Monday, December 11, 2023

Psychedelic Stock News: Red Light Holland's (CSE: TRIP) GMP Manufactured Psilocybin Microdosing Capsules Aimed to Be Distributed in Emerging Markets Pass Five Month Stability Testing by CCrest Laboratories in Montreal, Canada

Psychedelic Stock News: Red Light Holland's (CSE: TRIP) GMP Manufactured Psilocybin Microdosing Capsules Aimed to Be Distributed in Emerging Markets Pass Five Month Stability Testing by CCrest Laboratories in Montreal, Canada: Psychedelic Stock News: Red Light Holland's (CSE: TRIP) GMP Manufactured Psilocybin Microdosing Capsules Aimed to Be Distributed in Emerging Markets Pass Five Month Stability Testing by CCrest Laboratories in Montreal, Canada

Tuesday, November 28, 2023

Hemp Stock News: Hempacco (NASDAQ: HPCO) Launches THCA Vapes with Snoop Dogg at the MJBizCon in Las Vegas, Booth #7512

Hemp Stock News: Hempacco (NASDAQ: HPCO) Launches THCA Vapes with Snoop Dogg at the MJBizCon in Las Vegas, Booth #7512: Hemp Stock News: Hempacco (NASDAQ: HPCO) Launches THCA Vapes with Snoop Dogg at the MJBizCon in Las Vegas, Booth #7512

Investor Ideas Potcasts: Interview with Kaya Holdings (OTCQB: $KAYS) on the Sacred Mushroom Center - Pioneers with Psilocybin and Advocates for Mental Health; @KayaHoldings

Investor Ideas Potcasts: Interview with Kaya Holdings (OTCQB: $KAYS) on the Sacred Mushroom Center - Pioneers with Psilocybin and Advocates for Mental Health; @KayaHoldings

November 28, 2023 (Investorideas.com Newswire), Investorideas.com, a global news source covering leading sectors including marijuana and psychedelic stocks releases a special edition of the top rated Investor Ideas potcast (Cannabis Podcast).

In today’s episode, Investor Idea’s host Cali Van Zant speaks with CEO Craig Frank and Senior Consultant Dave Jones of Kaya Holdings Inc (OTCQB: KAYS).

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2023/112223-Cannabis.mp3

Read this in full at https://www.investorideas.com/news/2023/cannabis-potcasts/11281Interview-Kaya-Holdings.asp

Hear Investor ideas cannabis potcast on iTunes

Hear the investor ideas potcast on Spotify

Kaya Holdings, Inc. is a mind care company focusing on wellness and mental health through their operations in medical and recreational cannabis, CBD products and psychedelic treatment clinics.

Kaya has the historical distinction of being the first US publicly traded company to hold and operate cannabis licenses in “touch the plant” categories from when it commenced cannabis operations in Portland, Oregon in 2014.

In today’s podcast, management discusses the new opportunities in the medical psychedelic market and how Kaya Holdings is leading the way as an innovator and pioneer in the sector. They also talk about their recent milestone of opening one of the first state licensed Psilocybin Treatment Centers in the United States, in Portland, Oregon.

Host Cali Van Zant says, “What makes this podcast special is to hear management go deep and share their personal experiences and show that they care about community. We discuss mental health and how it personally affects us all. It is a rare opportunity to get such personal insight from a management team and the opportunity to find a public company with heart. I hope you all enjoy listening and share this interview.”

To learn more about Kaya holdings you can visit their website at (www.kayaholdings.com) or reach out to the team at info@kayaholdings.com

Today’s podcast overview

When talking about the new Sacred Mushroom space, CEO Craig Frank notes, “It is very important to us that the facility be in a central location because we think community is a big part of the healing process. We were very lucky to find the perfect location.”

“The space is the entire top floor of the Falcon Building in downtown Portland. At about 11,000 square feet, we have the area we need to offer both private and group experiences, as well as creativity centers, sensory rooms, reflection areas, and the room to roam and explore. We are equipped with a full kitchen and will be able to provide food consistent with Oregon regulation….

I think there are four primary differences between us and what we have seen so far. I would say the first difference is the space itself. A huge contributing factor in the quality of an experience is the setting and ours is extraordinary. Another difference would be the extent to which we aim to cater the journey to individual preference, with sound, sight, and scent options and the activity options presented. Third, I would say the community we seek to create. While we will cater to out-of-state visitors, our emphasis is on serving the needs of the Greater Portland area. Finally, I would say our pricing model is different. We are aiming to enable sustained treatment to those who seek it, so we have some less expensive microdosing options.”

When talking about other companies in the psilocybin space, he went on to say, “The work of companies like ATAI Life Sciences (NASDAQ: ATAI) and Compass Pathways (NASDAQ:CMPS) is fascinating and we are excited to see what their research can teach all of us about the medicinal possibilities of psilocybin.

CMPS is developing its own synthetic versions of that they then plan to administer in their own treatment facilities. Our model calls for the use of natural psilocybin and psilocin in our own facilities. We believe our model is more immediate and allows us to avoid the long, laborious, and very costly FDA process. We expect to begin offering treatments immediately upon licensing of our facility…”

When talking about the personal reasons for building a treatment center and working in the Psilocybin space, Frank says, “I would say that it is hard to find an American family that does not have someone with a mental disorder effecting their personal story whether it be a sibling, a parent, a child, or a friend. There is something in the way we live that causes profound pain and disorder in some people and our involvement is in some ways motivated to bring this relief; to those we love and those other people love.”

About Kaya Holdings, Inc. (www.kayaholdings.com )

Kaya Holdings, Inc is a "mind care" company with operations in medical/recreational cannabis and pending operations in the emerging psilocybin sector. KAYS is a fully reporting, US-based publicly traded company, listed for trading on the over-the-counter market under the symbol KAYS.

In 2014, KAYS became the first US public company to own and operate a medical cannabis dispensary (in Portland, Oregon). The Company still operates the original Kaya Shack™ cannabis dispensary while seeking to shift our cannabis operations to serve the European Union. KAYS has interests in three medical cannabis licenses (2 in Greece, 1 in Israel) to advance this effort.

Resuming its role as innovator and trend setter, the Company is again breaking ground in the United States with the planned introduction of psilocybin treatment centers through our majority owned subsidiary, Fifth Dimension Therapeutics, Inc. ("FDT").

About Investorideas.com - Big Investing Ideas

Investorideas.com is a platform for investing ideas. We publish breaking stock news, stock research, guest posts and create original top rated investing podcasts, plus sector tag articles featuring up and coming companies and industry leaders. Investor Idea’s original branded content includes the Crypto Corner Podcast , Play by Play Sports Podcast , Cannabis News and Stocks on the Move Podcast , Cleantech and Climate Change Podcast, Exploring Mining Podcast , Betting on Gaming Stocks Podcast and the AI Eye Podcast. We also create free investor stock directories for AI and tech, biotech, cannabis, cleantech, crypto, defense, gaming, health and wellness, mining, oil and gas, sports and water.

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

The Investorideas.com podcasts are also available on iTunes (Apple Podcasts), Audible, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Podcasts and most audio platforms available.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure: KAYS is a paid for monthly featured stock on Investorideas.com. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

Contact Investorideas.com

800 665 0411

Investorideas.com potcasts - Listen Daily to Investor Ideas Potcasts #Cannabis News and Stocks on the Move

Check out our stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana / Hemp Stocks plus the new psychedelic stock directory!

Follow Pot stocks news - Get News Alerts on Marijuana Stocks

Tuesday, November 14, 2023

Cannabis Stock News: Body and Mind (CSE: BAMM) Announces Fiscal Year End (July) 2023 Financial Results

Cannabis Stock News: Body and Mind (CSE: BAMM) Announces Fiscal Year End (July) 2023 Financial Results: Cannabis Stock News: Body and Mind (CSE: BAMM) Announces Fiscal Year End (July) 2023 Financial Results

Friday, November 10, 2023

New #InvestorIdeas (CSE: $AUEX.C) (CSE: $KOG.C) (CSE: $REDC.C) (NYSE: $TMO) (CSE: $METX.C) (CSE: $XTCY.C) (CSE: $ICS.C)

New #InvestorIdeas (CSE: $AUEX.C) (CSE: $KOG.C) (CSE: $REDC.C) (NYSE: $TMO) (CSE: $METX.C) (CSE: $XTCY.C) (CSE: $ICS.C)

New #Stocks to watch in #Mining, #Biotech, #Cannabis and #Cybersecurity

November 10, 2023 – (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces its weekly roundup of stocks to watch in Mining, Biotech, Cannabis and Cybersecurity. Today’s stocks have been added to our lists of free stock directories in each sector.

Read this in full at https://www.investorideas.com/news/2023/main/11101Stocks.asp

The newest mining companies are all CSE-listed and operations are involved in gold and copper resources.

The latest biotech companies include a cross-over into nanotech and immune-oncology therapeutics.

The newest cannabis company is a prospect generator in hemp and CBD-related, psilocybin and functional mushrooms, while the latest cybersecurity company is a managed security service provider (MSSP).

New Stocks Added to the Mining Directories:

Advanced Gold Exploration Inc.(CSE:AUEX) - formerly Advance United Holdings Inc. - is an exploration stage mineral resources company whose principal business activities include acquiring, exploring and evaluating strategic mineral properties.

KO Gold (CSE:KOG) is a Canadian private exploration company focused on exploring the world-class Otago Gold District on the South Island of New Zealand.

Red Canyon Resources Ltd (CSE:REDC) is a mineral resource company principally engaged in the acquisition and exploration of mineral resource properties. Its objective is to locate and develop copper and associated precious metals, focusing initially on the exploration and development of its principal project, the Peak Property, located in British Columbia, Canada. The Company also holds a secondary property, the Scraper Springs Property.

New stocks added to the Biotech Directories:

Thermo Fisher Scientific Inc. (NYSE:TMO) is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.

ME Therapeutics Holdings Inc. (CSE: METX) is an early stage Vancouver based biotechnology company involved in the discovery and development of novel immuno oncology therapeutics targeting immune suppression in cancer. Our main focus is on overcoming the suppressive effects of an important class of immune cells called myeloid cells in order to enhance anti-tumour immunity.

New Stocks Added to Cannabis Directory:

Xtacy Therapeutics Corp (CSE:XTCY) Formerly Global Wellness Strategies Inc.- is a prospect generator that provides high growth companies with financial, operational, and management assistance in the fast-growing market for wellness consumer products. The present focus of the company is in hemp and CBD-related, psilocybin and functional mushrooms, and health-care related industries.

New Stocks Added to Cybersecurity Directory:

Integrated Cyber Solutions Inc. (CSE:ICS) is a managed security service provider (MSSP) that humanizes cybersecurity managed services to the Small-to-Medium Business (SMB) and Small-to-Medium Enterprise (SME) sectors. They integrate capabilities from third-party cybersecurity providers, allowing companies to continuously adapt their services to evolving technologies and providers – ensuring customers have access to the latest cybersecurity solutions. Apart from providing essential cybersecurity services, Integrated Cyber's managed services and IC360 technology platform consolidate vast amounts of information to generate actionable intelligence from the numerous software point solutions within their customer's environments. The results enable simple, understandable, and actionable insights to help customers comprehend and better secure their organization. Integrated Cyber greatly emphasizes the human aspect of cybersecurity management, simplifying complex concepts, and highlighting the crucial role that employee behavior plays in a company's cyber defenses.

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

About Investorideas.com - Big Investing Ideas

Public companies within the sectors we cover use our news and content services to tell their story to interested investors. Paid for content is disclosed.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Learn more about our news, PR and social media, podcast and ticker tag services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

Learn more about advertising and guest posts

https://www.investorideas.com/Advertise/

Contact Investorideas.com to be added to our stock directories or learn more about us

Dawn Van Zant and Cali Van Zant

800 665 0411

Thursday, November 9, 2023

Hemp Stock News: Hempacco (NASDAQ: HPCO) and Ispire Sign Landmark Manufacturing Agreement Revolutionizing the Global Vape Scene with Celebrity Products Headlining with Snoop Dogg

Hemp Stock News: Hempacco (NASDAQ: HPCO) and Ispire Sign Landmark Manufacturing Agreement Revolutionizing the Global Vape Scene with Celebrity Products Headlining with Snoop Dogg: Hemp Stock News: Hempacco (NASDAQ: HPCO) and Ispire Sign Landmark Manufacturing Agreement Revolutionizing the Global Vape Scene with Celebrity Products Headlining with Snoop Dogg

Wednesday, November 8, 2023

Gallup: More Americans Than Ever Say "Marijuana Should Be Legal"

Gallup: More Americans Than Ever Say "Marijuana Should Be Legal": Gallup: More Americans Than Ever Say Marijuana Should Be Legal

Tuesday, November 7, 2023

Cannabis Stock News: City View Green Holdings Inc. (CSE: CVGR) Announces Strategic Review

Cannabis Stock News: City View Green Holdings Inc. (CSE: CVGR) Announces Strategic Review: Cannabis Stock News: City View Green Holdings Inc. (CSE: CVGR) Announces Strategic Review

Breaking #Psilocybin #Stock News: Kaya Holdings (OTCQB: $KAYS) Unveils "The Scared Mushroom(TM)", the First US-Based Psilocybin Center to be Operated by a US Public Company; @KayaHoldings

Breaking #Psilocybin #Stock News: Kaya Holdings (OTCQB: $KAYS) Unveils "The Scared Mushroom(TM)", the First US-Based Psilocybin Center to be Operated by a US Public Company; @KayaHoldings

FT. LAUDERDALE, FL - November 7, 2023 (Investorideas.com Newswire) Kaya Holdings, Inc., ("KAYS" or the "Company") (OTCQB:KAYS) has shared the company's progress to open "The Sacred Mushroom™" Psilocybin Facilitation Center in Portland, Oregon and invites interested parties to view the project presentation.

Read this news, featuring KAYS in full at https://www.investorideas.com/CO/KAYS/news/2023/11071The-Scared-Mushroom.asp

The Sacred Mushroom™ has approximately 11,000 sq ft. and will provide visitors with access to many distinctive treatment experiences including private treatment rooms and group session areas, activity zones with yoga, listening stations, journaling chairs, and art expression, special "sensation rooms", and a special approach to microdosing.

To read and download the report click the following link:

https://www.dropbox.com/scl/fi/0g2s330k3nbycagpt78bd/The-Sacred-Mushroom-2023-10-31.pdf?rlkey=499ov1u678mc1iqgc2zcc8v95&dl=0

KAYS SHAREHOLDERS AND OTHER INTERESTED PARTIES - PLEASE UPDATE YOUR CONTACT INFORMATION

We routinely receive calls and emails from shareholders asking us questions about KAYS, so we are asking all KAYS shareholders to email us and confirm their contact info. Please email info@kayaholdings.com with "KAYS shareholder update" in the subject line and include your name, address, phone number and number of shares you own so that we may make sure you receive all updates and can respond to any shareholder inquiries. If you would like to speak to someone at the Company, please call ore text 954-480-3960 and someone will get right back to you.

About Kaya Holdings, Inc. (www.kayaholdings.com)

In 2014 KAYS became the first US public company to own and operate a medical cannabis dispensary (in Portland, Oregon). The Company still operates the original Kaya Shack™ cannabis dispensary while seeking to shift our cannabis operations to serve the European Union. KAYS has interests in three medical cannabis licenses (2 in Greece, 1 in Israel) to advance this effort.

KAYS subsidiaries include:

Fifth Dimension Therapeutics, Inc. serves as the Company's operating branch in the psychedelic treatment sector, including operation of mushroom cultivation facilities and The Scared Mushroom™ treatment centers.

Marijuana Holdings Americas, Inc. owns the Kaya Shack™ brand of licensed medical and recreational marijuana stores (www.kayashack.com) and the Kaya Farms™ brand of cannabis production and processing operations in the United States.

Kaya Brands International, Inc., serves as the vehicle for the Company's non-U.S. operations including cultivation activities under development in Greece and Israel.

Kaya Brands USA, Inc. owns a wide range of proprietary brands of cannabis extracts, oils, pre-rolls, topicals, edibles and beverages, cannaceuticals and related accessories.

Important Disclosure

KAYS is planning execution of its stated business objectives in accordance with current understanding of state and local laws and federal enforcement policies and priorities as it relates to psychedelics and cannabis. Potential investors and shareholders are cautioned that KAYS and subsidiaries including FDT will obtain advice of counsel prior to actualizing any portion of their business plan (including but not limited to license applications for the cultivation, distribution or sale of marijuana and psychedelic products, engaging in said activities or acquiring existing production/sales operations). Advice of counsel with regard to specific activities of KAYS, federal, state or local legal action or changes in federal government policy and/or state and local laws may adversely affect business operations and shareholder value. Additionally, the launch of The Sacred Mushroom™ Psilocybin Treatment Center is dependent, among other matters, on final Oregon Health Authority ("OHA") licensing and receipt of final financing from our investors.

Forward-Looking Statements

This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, acceptance of the Company's current and future products and services in the marketplace, the ability of the Company to develop effective new products and receive regulatory approvals of such products, competitive factors, dependence upon third-party vendors, and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.

SOURCE: Kaya Holdings

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure: this news content featuring Kaya Holdings, Inc. (OTCQB:KAYS) is paid for content . Learn more Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Kaya Holdings, Inc. (OTCQB: KAYS) is a featured Cannabis stock on Investorideas.com Visit profile page

Get News Alerts on KAYA Holdings (KAYS)

Investorideas.com potcasts - Listen Daily to Investor Ideas Potcasts #Cannabis News and Stocks on the Move

Check out our stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana / Hemp Stocks plus the new psychedelic stock directory!

Follow Pot stocks news - Get News Alerts on Marijuana Stocks

Friday, November 3, 2023

CBD Stock News: CBD of Denver Inc. (OTC Pink: CBDD) Announces Q3 Results, Update on Anti-Slip, Expansion of Magic Lappen, Luxora Investor Call and Update Additional Corporate Actions

CBD Stock News: CBD of Denver Inc. (OTC Pink: CBDD) Announces Q3 Results, Update on Anti-Slip, Expansion of Magic Lappen, Luxora Investor Call and Update Additional Corporate Actions: CBD Stock News: CBD of Denver Inc. (OTC Pink: CBDD) Announces Q3 Results, Update on Anti-Slip, Expansion of Magic Lappen, Luxora Investor Call and Update Additional Corporate Actions

Thursday, November 2, 2023

Psilocybin Stock News: Red Light Holland (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) Engages Dr. Taras Nahirny, as Advisor to Help with Distribution of Company Homogenized Psilocybin Microdosing Capsules

Psilocybin Stock News: Red Light Holland (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) Engages Dr. Taras Nahirny, as Advisor to Help with Distribution of Company Homogenized Psilocybin Microdosing Capsules: Psilocybin Stock News: Red Light Holland (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) Engages Dr. Taras Nahirny, as Advisor to Help with Distribution of Company Homogenized Psilocybin Microdosing Capsules

Friday, October 20, 2023

CBD Stock News: CBD of Denver Inc. (OTC Pink: CBDD) Anticipates Accelerated Growth of Berlin R13 Anti Slip Due to Improved German Regulation, Investor Call for Luxora, Additional Corporate Actions

CBD Stock News: CBD of Denver Inc. (OTC Pink: CBDD) Anticipates Accelerated Growth of Berlin R13 Anti Slip Due to Improved German Regulation, Investor Call for Luxora, Additional Corporate Actions: CBD Stock News: CBD of Denver Inc. (OTC Pink: CBDD) Anticipates Accelerated Growth of Berlin R13 Anti Slip Due to Improved German Regulation, Investor Call for Luxora, Additional Corporate Actions

Thursday, October 19, 2023

Pioneers and Innovators in #Psilocybin Treatments (OTCQB: $KAYS) (NASDAQ: $CMPS) (NYSE: $CYBN) (OTC: $MSSTF) @COMPASSPathway @CybinInc @MindsetPharma

Pioneers and Innovators in #Psilocybin Treatments (OTCQB: $KAYS) (NASDAQ: $CMPS) (NYSE: $CYBN) (OTC: $MSSTF) @COMPASSPathway @CybinInc @MindsetPharma

How #BigPharma wants in on the Game

October 19, 2023 - Investorideas.com (https://www.investorideas.com) a global investor news source covering psilocybin and psychedelic health and wellness stocks releases a special news report featuring Kaya Holdings, Inc. (OTCQB:KAYS). As psilocybin and other alternative health innovators try to shape the future of mental health, Pharma and traditional healthcare investors are watching and waiting to get their share.

Read this article, featuring KAYS in full at https://www.investorideas.com/news/2023/cannabis/10191Psilocybin-Treatments.asp

According to recent research published in September, “In recent years, the potential therapeutic benefits of psychedelics have been well documented, with research suggesting that these compounds can be effective for treating a range of mental health disorders, from depression and anxiety to addiction. Additionally, research has shown that psychedelics may be effective in promoting personal growth and well-being. As a result, many pharmaceutical companies and research institutions have increased their focus on developing psychedelic-based treatments. It was observed that in 2021, nearly USD 2 billion had been invested in the psychedelics sector in over 60 financing events during the past year.”

Seeing the growing opportunity, Kaya Holdings, Inc. (OTCQB:KAYS) is the only U.S. public company engaged in securing an Oregon Health Authority (“OHA”) license to open a psilocybin treatment center.

Kaya Holdings just announced that it has closed an additional round of bridge financing targeted to complete KAYS' planned psilocybin treatment center in Portland, Oregon. The facility will operate under the name "The Sacred Mushroom™.

Total funds received from our bridge financing since the first installment was received in June 2023, are $600,000, with no commissions or fees associated with the financing. The funds are not convertible into KAYS stock. $100K of the funds are in the form of short-term financing with repayment due March 15, 2023, and $500K is due to be repaid from 10% of KAYS' revenues quarterly, with any unpaid balance due June 30, 2025.

Continued: We believe that KAYS is presently the only U.S. public company engaged in securing an Oregon Health Authority ("OHA") license to open a psilocybin treatment center, aiming to create a setting that is unmatched by any other facility and providing access to relief from treatment-resistant mental health conditions, including depression, anxiety, additions, and eating disorders.

Continued: A recently published report on psilocybin treatment prices in Oregon showed that Initial prices for one facility range from $300 for a group microdose session to $3,500 for an individual high-dose session, with another facility pricing first-time full-dose treatments at $15,000 (these prices do not include the cost of the psilocybin, which can run from $300 to $500).

KAYS expects its planned model facility to offer a superior setting, broader activity and treatment options, integrated cultivation and processing, and accessible pricing, thereby enabling us to deliver a superior treatment experience at a much lower price than the competition, while still achieving profitability.

The Sacred Mushroom™ has approximately 11,000 sq ft. and will provide visitors with access to our microdosing café, private treatment rooms and group session areas, and activity zones with yoga, listening stations, journaling chairs, and art expression for distinctive, effective, and positive psilocybin treatments.

Continued: KAYS expects to complete its initial license application within the next 30 days, and subject to OHA approval, intends to bring the facility online within 90 days. KAYS plans to operate The Sacred Mushroom™ as part of its Fifth Dimension Therapeutics, Inc. subsidiary ("FDT"), which also plans to work cooperatively with select pharmaceutical companies to maximize the curative potential of psilocybin.

COMPASS Pathways plc (NASDAQ:CMPS) is pioneering the development of a new model of psilocybin treatment, in which its proprietary formulation of synthetic psilocybin, COMP360, is administered in conjunction with psychological support. COMP360 has been designated a Breakthrough Therapy by the US Food and Drug Administration (FDA) and has received Innovative Licensing and Access Pathway (ILAP) designation in the UK for treatment-resistant depression (TRD).

Evidencing that traditional healthcare investors are now betting on psilocybin and psychedelic health and wellness, COMPASS announced in August a $285 Million Private Placement financing joined by leading healthcare Investors.

From the news: Kabir Nath, Chief Executive Officer of COMPASS Pathways, said, “We are grateful for the support of this group of leading healthcare investors for our work to bring potentially transformative treatment for mental health conditions to patients urgently in need of better options. We thank these investors for their confidence in our rigorous approach to building a strong base of evidence for the potential of COMP360 psilocybin treatment to help people with treatment-resistant depression (TRD), post-traumatic stress disorder and anorexia nervosa. We expect that the net proceeds will allow us to advance our pivotal phase 3 program in TRD and achieve important milestones in the development of COMP360. We view this investment as a validation of the potential of psychedelic medicine and the importance of a rigorous and evidence-based approach.”

Cybin Inc. (NYSE: CYBN) is a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions.

Breaking through into mainstream, Cybin recently presented an abstract and moderated a Psychedelic Workshop at the 6th Annual Neuropsychiatric Drug Development Summit.

From the news: Cybin announced that its abstract describing a comprehensive structure-activity relationship study of a series of novel serotonergic phenethylamines has been selected for presentation at the Neuropsychiatric Drug Development Summit taking place October 11-12 in Boston, MA.

The abstract, entitled "Structure-activity of 2C-X psychedelics to develop a novel 5-HT2A receptor full agonist with therapeutic potential," summarizes the studies, which identified multiple potential compounds of therapeutic potential with attractive drug-like characteristics, including good safety profile, high oral bioavailability and brain penetration.

"We are extremely pleased that our abstract was selected for presentation, as this is foundational research that will inform the selection of a potential future development candidate. The Neuropsychiatric Drug Development Summit is a unique opportunity to engage with innovators in neuropsychiatry and to share ideas that ultimately drive the field forward," said Doug Drysdale, Chief Executive Officer of Cybin.

According to Medtech Pulse last year, “The major pharmaceutical companies have largely stayed out of the psychedelics market. The most active player among them is Otsuka with its investments in Compass Pathways (NASDAQ:CMPS) and Mindset Pharma (OTC: MSSTF).”

In August, Mindset Pharma, a drug discovery company developing novel, optimized, next-generation psychedelic and non-psychedelic medications to treat neuropsychiatric and neurological disorders with unmet medical needs, announced that they have entered into a definitive arrangement agreement (the "Agreement") pursuant to which Otsuka Pharmaceutical Co., Ltd. ("Otsuka"), through its wholly-owned subsidiary Otsuka America, Inc. ("OAI") will acquire all of the outstanding shares of Mindset by way of a statutory plan of arrangement for approximately CAD $80 million in an all-cash transaction (the "Transaction").

Continued from Medtech Pulse: “Experts expect big pharma companies to step in as soon as the startups are closer to approval.”

Reporting on the Mindset Pharma (OTC: MSSTF) deal, Psychedelicspotlight.com said, “Big Pharma has certainly taken note of the potential therapeutic benefits of psychedelics. Otsuka, a major Japanese Pharmaceutical company, recently signed an agreement to acquire Canada's Mindset Pharma, which specializes in developing psychedelic medications for neuropsychiatric disorders.”

“The move is reflective of the growing body of scientific evidence that indicates psychedelics may hold promise in areas such as addiction, depression, and anxiety.”

As ResearchNester pointed out recently, “The increasing investment from venture capitalists and the rising number of patent filings for psychedelics-related drugs are expected to further boost the market growth in the upcoming years. Additionally, the increasing number of collaborations between academic institutes and pharmaceutical companies are expected to drive the market growth.”

As big Pharma chases the long term opportunity, investors can watch the small innovators like Kaya Holdings, Inc. (OTCQB: KAYS) pave the way with alternative health treatments that can be used by patients in treatment centers today!

Investors following psilocybin and health and wellness stocks stocks can use the free stock directory at Investor Ideas

https://www.investorideas.com/LOHAS-investing/Stock_List.asp

About Investorideas.com - Big Investing Ideas

Public companies within the sectors we cover can use our news publishing and content creation services to help tell their story to interested investors.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure: Kaya Holdings, Inc.(OTCQB:KAYS) is a paid featured monthly stock on Investorideas.com More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Contact Investorideas.com

800-665-0411

Investorideas.com potcasts - Listen Daily to Investor Ideas Potcasts #Cannabis News and Stocks on the Move

Check out our stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana / Hemp Stocks plus the new psychedelic stock directory!

Follow Pot stocks news - Get News Alerts on Marijuana Stocks

about Investorideas.com

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .